March 2013 - Volume 20 - Issue 3 - Contributor Index

Alphabetical Search
O
Q
U
Y

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Andersen, Shaneda Warren; Trentham-Dietz, Amy; Figueroa, Jonine D.; More

Menopause. 20(3):354-358, March 2013.

Hyaluronic acid concentration in postmenopausal facial skin after topical estradiol and genistein treatment: a double-blind, randomized clinical trial of efficacy

Patriarca, Marisa Teresinha; Barbosa de Moraes, Andréa Regina; Nader, Helena B.; More

Menopause. 20(3):336-341, March 2013.

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Andersen, Shaneda Warren; Trentham-Dietz, Amy; Figueroa, Jonine D.; More

Menopause. 20(3):354-358, March 2013.

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Andersen, Shaneda Warren; Trentham-Dietz, Amy; Figueroa, Jonine D.; More

Menopause. 20(3):354-358, March 2013.

Author:
Emaus, Aina MD

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Andersen, Shaneda Warren; Trentham-Dietz, Amy; Figueroa, Jonine D.; More

Menopause. 20(3):354-358, March 2013.

Hyaluronic acid concentration in postmenopausal facial skin after topical estradiol and genistein treatment: a double-blind, randomized clinical trial of efficacy

Patriarca, Marisa Teresinha; Barbosa de Moraes, Andréa Regina; Nader, Helena B.; More

Menopause. 20(3):336-341, March 2013.

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Andersen, Shaneda Warren; Trentham-Dietz, Amy; Figueroa, Jonine D.; More

Menopause. 20(3):354-358, March 2013.

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Andersen, Shaneda Warren; Trentham-Dietz, Amy; Figueroa, Jonine D.; More

Menopause. 20(3):354-358, March 2013.

Hyaluronic acid concentration in postmenopausal facial skin after topical estradiol and genistein treatment: a double-blind, randomized clinical trial of efficacy

Patriarca, Marisa Teresinha; Barbosa de Moraes, Andréa Regina; Nader, Helena B.; More

Menopause. 20(3):336-341, March 2013.

Hyaluronic acid concentration in postmenopausal facial skin after topical estradiol and genistein treatment: a double-blind, randomized clinical trial of efficacy

Patriarca, Marisa Teresinha; Barbosa de Moraes, Andréa Regina; Nader, Helena B.; More

Menopause. 20(3):336-341, March 2013.

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Andersen, Shaneda Warren; Trentham-Dietz, Amy; Figueroa, Jonine D.; More

Menopause. 20(3):354-358, March 2013.

Hyaluronic acid concentration in postmenopausal facial skin after topical estradiol and genistein treatment: a double-blind, randomized clinical trial of efficacy

Patriarca, Marisa Teresinha; Barbosa de Moraes, Andréa Regina; Nader, Helena B.; More

Menopause. 20(3):336-341, March 2013.

Hyaluronic acid concentration in postmenopausal facial skin after topical estradiol and genistein treatment: a double-blind, randomized clinical trial of efficacy

Patriarca, Marisa Teresinha; Barbosa de Moraes, Andréa Regina; Nader, Helena B.; More

Menopause. 20(3):336-341, March 2013.

Hyaluronic acid concentration in postmenopausal facial skin after topical estradiol and genistein treatment: a double-blind, randomized clinical trial of efficacy

Patriarca, Marisa Teresinha; Barbosa de Moraes, Andréa Regina; Nader, Helena B.; More

Menopause. 20(3):336-341, March 2013.

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Andersen, Shaneda Warren; Trentham-Dietz, Amy; Figueroa, Jonine D.; More

Menopause. 20(3):354-358, March 2013.

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Andersen, Shaneda Warren; Trentham-Dietz, Amy; Figueroa, Jonine D.; More

Menopause. 20(3):354-358, March 2013.

1 2 Next